Logo

Bliss GVS Pharma Ltd. Share Price

Pharmaceuticals & Drugs

Bliss GVS Pharma Ltd. (INR)124.871.7   (1.3%)

Exchange ScripsBSE506197NSEBLISSGVSISININE416D01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Bliss GVS Pharma Ltd. Performance

Market performance

Open price122.71
High126.5
Volumes334016
Prev Close124.87
Low122.61
Closing date2025-04-17

Historical performance

1 Year High185.50
3 Year High185.50
5 Year High221.00
1 Year Low92.15
3 Year Low67.40
5 Year Low66.10

Bliss GVS Pharma Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
1314
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
17.33
Dividend Yield
Dividend Yield
0.4 %

Bliss GVS Pharma Ltd. Investment Returns

1 Year
11.3%
3 Years
50.2%
5 Years
24.8%
10 Years
-7.8%

Bliss GVS Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA121.62Bullish
10-DMA121.12Bullish
20-DMA120.83Bullish
50-DMA128.16Bearish
100-DMA144.65Bearish
200-DMA133.47Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors4951049551529304473045150
Government---------------

Bliss GVS Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income304178315220
Operating Profit1794135114981286
Interest691044772
Depreciation264187173172
Profit Before Tax116910615421041
Consolidated Net Profit755709150685
Adjusted EPS7717

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital105104104103
Total Reserves9490864679847881
Minority Interest358335278197
Total Non-Current Liabilities511428292452
Total Liabilities12139115351108710768
Capital Work in Progress782822224
Total Assets12139115351108710768

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities15243431355640
Cash Flow from Investing Activities-1328-78-930-470
Cash Flow from Financing Activitie-209-249-237-208
Net Cash Inflow / Outflow-1316188-38
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.33.
  • 3Y Stock Price CAGR of the stock is 14.5.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹1794 Million.
  • The company generated revenue of ₹7702 Million in the previous financial year.

Bliss GVS Pharma Ltd.

124.871.7   (1.3%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1079723.3
No. of Shares: 8646.8
Performance:8%
P/L: ₹79723.3

Top Gainers

SymbolChange%
SECMARK124.29(20%)
OSWALGREEN43.33(18%)
FACT760.85(14%)
OSWALAGRO96.73(13%)
SMSLIFE1435.2(13%)

Top Losers

SymbolChange%
VIKASLIFE2.59(-9%)
ROML50.49(-7%)
ROSSELLIND77.66(-6%)
DYNPRO291(-6%)
SONATSOFTW314.7(-6%)
TREJHARA232.28(-6%)
GATECHDVR1.05(-5%)
MGEL14.23(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

65.8

56.06

March 20 - April 20

Brooks Laboratories Ltd.

41.3

139.77

March 20 - April 20

SMS Lifesciences India Ltd.

37.2

1435.2

March 20 - April 20

Panacea Biotec Ltd.

33.5

522.95

March 20 - April 20

Bal Pharma Ltd.

28.9

104.91

March 20 - April 20

Kopran Ltd.

27.8

202.58

March 20 - April 20

Wanbury Ltd.

27.2

263.47

March 20 - April 20

Hester Biosciences Ltd.

24.5

1774.9

March 20 - April 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month